Skip to main content
OpenTrials
Completed

NCT Number: NCT01542346

Subcutaneous Adaption and Cosmetic Outcome Following Caesarean Delivery

This is a double blinded randomized study investigating if subcutaneous adaption has an impact on cosmetic outcome after Caesarean delivery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Klinikum Klagenfurt am Woerthersee

Klagenfurt, Carinthia, 9020, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women undergoing cesarean section for any indication
  • literate in german language

Exclusion criteria

  • history of keloids
  • previous transversal suprapubic scars
  • known patient hypersensitivity to any of the suture materials used in the protocol
  • a medical disorder that could affect wound healing (eg, diabetes mellitus, chronic corticosteroid use)

Treatment and study plan

subcutaneous adaption

Procedure

Primary outcomes

  1. Objective and subjective cosmetic appearance

    Time frame: after 6 months

Secondary outcomes

  1. Surgical site infection and wound breakdown

    Time frame: within 30 days after surgery

  2. Haematoma

    Time frame: within 5 days after surgery

Sponsors and collaborators

Lead sponsor

Klinikum Klagenfurt am Wörthersee

Other

Registry information

Important dates

Study start
2012
First posted
Mar 2, 2012
Registry last updated
Jul 15, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.